News & Perspective
Drugs & Diseases
CME & Education
Academy
Video
Decision Point

Specialty: Multispecialty
Allergy & Immunology
Anesthesiology
Cardiology
Critical Care
Dermatology
Diabetes & Endocrinology
Emergency Medicine
Family Medicine
Gastroenterology
General Surgery
Hematology - Oncology
HIV/AIDS
Hospital Medicine
Infectious Diseases
Internal Medicine
Multispecialty
Nephrology
Neurology
Ob/Gyn & Women's Health
Oncology
Ophthalmology
Orthopedics
Pathology & Lab Medicine
Pediatrics
Plastic Surgery
Psychiatry
Public Health
Pulmonary Medicine
Radiology
Rheumatology
Transplantation
Urology
Today on Medscape
Business of Medicine
Medical Lifestyle
Science & Technology
Medical Students
Nurses
Pharmacists
Residents
Edition: English

Medscape

English
Deutsch
Español
Français
Português
UKNew

Univadis

Sign Up It's Free!
English Edition

Medscape

Univadis

    X
    Univadis from Medscape

    No Results

      Thursday, December 7, 2023
      News & Perspective Drugs & Diseases CME & Education Academy Video Decision Point
      Perspective > Medscape Pharmacists > Food and Drug Administration Approvals

      August 2003

      Jane S. Ricciuti, RPh, MS

      Disclosures

      August 28, 2003

      In This Article

      Introduction

      The US Food and Drug Administration (FDA) has approved 2 new antiviral agents for HIV infection -- Emtriva (emtricitabine) and Reyataz (atazanavir). Emtricitabine is a synthetic nucleoside analogue and atazanavir is an azapeptide inhibitor.

      This month's column reviews FDA new product approvals and labeling changes for:

      Alzheimer's Disease Agents

      • Cognex (tacrine) Capsules

      Antiasthmatic Agents

      • Foradil (formoterol fumarate) Aerolizer Inhalation Powder

      Antihemophilic Product

      • Advate (Antihemophilic Factor [Recombinant], Plasma/Albumin Free Method [rAHF-PFM])

      Antihypertensive Agents

      • Cardura (doxazosin mesylate) Tablets

      Anti-infective Agents

      • Lariam (mefloquine hydrochloride) Tablets

      Antineoplastic Agents

      • Bexxar (tositumomab and Iodine I 131 tositumomab)

      Antiviral Agents

      • Emtriva (emtricitabine) Capsules

      • Reyataz (atazanavir sulfate) Capsules

      Cardiovascular Agents

      • Pravigard PAC (copackaged 20, 40 or 80 mg pravastatin sodium and 81 or 325 mg buffered aspirin) Tablets

      Estrogens

      • Premarin (conjugated estrogens) Tablets

      Growth Hormones

      • Humatrope (somatropin, rDNA origin) Injection

      Pulmonology Agents

      • Zemaira (alpha-1-proteinase inhibitor [human] Intravenous Injection

      Rheumatologic Agents

      • Kineret (anakinra) Injection

      • Enbrel (etanercept) Injection

      Urology Agents

      • Uroxatral (alfuzosin hydrochloride) Extended Release Tablets

      Vaccines

      • Infanrix (Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed)

      Comments

      3090D553-9492-4563-8681-AD288FA52ACE
      Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.

      processing....

      Feedback
      Help us make reference on Medscape the best clinical resource possible. Please use this form to submit your questions or comments on how to make this article more useful to clinicians.
      Pleasedo not use this form to submit personal or patient medical information or to report adverse drug events. You are encouraged to report adverse drug event information to the FDA.
      Find Us On
      About
      About Medscape Privacy Policy Editorial Policy Cookies Terms of Use Advertising Policy Help Center
      Membership
      Become a Member About You Professional Information Newsletters & Alerts Market Research
      App
      Medscape
      WebMD Network
      Medscape Live Events WebMD MedicineNet eMedicineHealth RxList WebMD Corporate Medscape UK
      Editions
      English Deutsch Español Français Português UK
      All material on this website is protected by copyright, Copyright © 1994-2023 by WebMD LLC. This website also contains material copyrighted by 3rd parties.